U.S. Clinical Nutrition Market Size

U.S. Clinical Nutrition Market Size

U.S. Clinical Nutrition Market size was over USD 12 billion in 2022 and will grow at over 9% CAGR from 2023 to 2032, driven by the increasing incidence of chronic diseases and metabolic diseases in the U.S.

To get key market trends

  Download Free Sample

Surging prevalence of non-communicable and chronic diseases such as type 2 diabetes, cardiovascular disorders, obesity, and others that require prolonged hospitalization has increased awareness of clinical nutrition in the U.S. As per the Sudden Cardiac Arrest Foundation, out-of-hospital cardiac arrests affect over 356,000 people every year in the U.S., of which 90% are fatal.

Growing government investments to improve nutrition security in the country are further expected to bolster the industry outlook. For instance, in November 2022, the USDA announced an investment of around USD 59.4 million to improve dietary health and nutrition security in the country.

Despite such an optimistic scenario, tightening government norms related to clinical nutrition products may pose challenges to industry expansion. The U.S. FDA regulates clinical nutrition products under a different set of regulations than those of traditional food and drug products. As per the Dietary Supplement Health and Education Act of 1994, the marketing of misbranded clinical nutrition products is strictly prohibited. Additionally, FDA holds the authority to take action against such products after they reach the market.